Dali B. Kodzoeva

Dali B. Kodzoeva

Auto-generated profile, based on publicly available information

Dali B. Kodzoeva

P.A. Hertsen Moscow Oncology Research Institute – branch of the National Medical Research Radiological Center, Ministry of Health of Russia

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 May 2025 in Journal of Modern Oncology
Verified
Journal Article
Open access
PDF file
UKUmar Kh. Khomidi
Umar Kh. Khomidi
MVMaria Yu. Vlasova
Maria Yu. Vlasova
ESErik K. Saribekyan
Erik K. Saribekyan
AZAziz D. Zikiryakhodzhaev
Aziz D. Zikiryakhodzhaev
SKShakhnoz G. Khakimova
Shakhnoz G. Khakimova
ХГХакимова Шахноз Голибовна
Хакимова Шахноз Голибовна
Breast cancer (BC) is still the most common cancer among the female population both in the Russian Federation and in the world. Surgical intervention is an important step in the complex treatment of patients with BC. Several variants of reconstructive plastic surgeries are of the greatest interest to oncologists-mammologists and plastic surgeons. Currently, practitioners have plenty of choices of synthetic and biological materials for reconstruction and many options for flap techniques. Despite the abundance of foreign and Russian publications, the issue of assessing the delayed results of breast reconstruction is still relevant. In our paper, we analyzed studies on long-term aesthetic outcomes of reconstructive surgeries with endoprostheses in patients with BC. The technique of endoprosthetics, compared to reconstruction using the patient's tissues, is simpler in technical terms, less traumatic, and the recovery time for patients is shorter. However, despite the use of high-quality implants and the improvement of reconstructive surgery techniques, there remains a certain risk of complications (15–35%). In the early postoperative period, the most common complications are protrusion and infection of the endoprosthesis, necrosis of the areola and wound edges, and implant rotation. Of the late complications, the most relevant is grade III–IV capsular contracture according to J. Baker. The studies emphasize the importance of an individual approach and careful planning of comprehensive treatment to achieve optimal outcomes and improve the quality of life of patients with BC.

4 March 2025 in Research and Practical Medicine Journal
Verified
Journal Article
Open access
PDF file
SASh. Sh. Abdulloeva
Sh. Sh. Abdulloeva
AKAndrei Kaprin
Andrei Kaprin
AZA. D. Zikiryakhodzhaev
A. D. Zikiryakhodzhaev
ESE. K. Saribekian
E. K. Saribekian
ERE. A. Rasskazova
E. A. Rasskazova
УХУ. Х. Хомиди
У. Х. Хомиди
Purpose of the study. To evaluate the results of targeted lymphadenectomy (TLAE) in patients with breast cancer (BC) cT1–3N1M0 after neoadjuvant systemic therapy (NAST). Patients and methods. The study represents a prospective analysis of 83 patients diagnosed with breast cancer in stage T1–3N1M0 who were treated in the Department of Reconstructive and Plastic Surgery of the breast and skin at the P. Hertsen Moscow Oncology Research Institute (Moscow, Russian Federation). The patients were divided into two groups: in the main group 1 (n = 45), TLAE was performed using a metal tag (clip) after surgery; in the control group 2 (n = 38), classical lymphadenectomy (LAE) was performed. The following characteristics were evaluated: the size of the primary tumor and its localization, the degree of malignan cy (G), the biological subtype of the tumor, the number of sentinel lymph nodes (SLN), the number of metastases in SLN, damage to other lymph nodes, the number of patients who moved from cN1 to cN0. According to these characteristics, the two groups were comparable and there were no statistically significant differences. The effectiveness of NAST was assessed by the frequency of complete pathomorphological regression of the lesion of the studied tissue. The frequency of identification of sentinel lymph nodes was assessed with urgent cytological and routine pathomorphological studies. Results. In group 1, a complete pathomorphological response in the mammary gland was 37.8 %, in group 2 – 31.6 %. A complete pathomorphological response in the affected lymph node (N0) after neoadjuvant polychemotherapy (NAST) was achieved in 51.1 % of patients in group 1 and 52.6 % in group 2. The frequency of identification of sentinel lymph nodes during biopsy in both groups was 100 %. The frequency of identification of the installed tag was 100 %. The frequency of coincidences of the clipped lymph node with the sentinel lymph node was 65 %. In one case, migration of the installed label was noted. The efficiency of using the navigation explorer was 93 %. Conclusion. The results obtained confirm the expediency, feasibility and high efficiency of de-escalation of surgical intervention in the form of TLAE. Our study also demonstrates the relative simplicity and accuracy of using a metal tag to achieve TLAE goals.

23 April 2024 in Plastic Surgery and Aesthetic Medicine
Verified
Journal Article
Closed access
ERE.A. Rasskazova
E.A. Rasskazova
AZA.D. Zikiryakhodzhaev
A.D. Zikiryakhodzhaev
AKAndrei Kaprin
Andrei Kaprin
DKD.B. Kodzoeva
D.B. Kodzoeva
The authors present multiple-stage breast reconstruction after previous skin-sparing mastectomy with single-stage autologous TRAM flap reconstruction and subsequent flap liponecrosis. The patient with left-sided breast cancer underwent treatment including neoadjuvant chemo- and radiotherapy. The last ones are risk factors of flap liponecrosis. Fat necrosis is a common complication after autologous breast reconstruction. This event may be asymptomatic in most cases and also symptomatic with necessary surgical intervention. If fat necrosis leads to flap loss, surgeons still have different options to recreate the breast from lipofilling of small defects to expanders and implants. This case report is important due to no clear guidelines for the management of patients with fat necrosis after autologous breast reconstruction.

21 August 2026 in MD-Onco
Verified
Journal Article
Open access
PDF file
DDD. S. Dzhabrailova
D. S. Dzhabrailova
ДШДжабраилова Д. Ш.
Джабраилова Д. Ш.
DKD. B. Kodzoeva
D. B. Kodzoeva
КБКодзоева Д. Б.
Кодзоева Д. Б.
AZA. D. Zikiryakhodzhaev
A. D. Zikiryakhodzhaev
ВНВолченко Н. Н.
Волченко Н. Н.
Background. Sentinel lymph node biopsy (SLNB) is the standard of regional staging in early-stage breast cancer (BC). However, contemporary randomized trials (SOUND, INSEMA, NAUTILUS) demonstrate the feasibility of safe axillary surgical de-escalation in a defined subset of patients with clinically node-negative (cN0) disease. Given the low rate of axillary lymph node metastases and the limited sensitivity of SLNB, this procedure may represent overtreatment in a proportion of patients. Aim. To evaluate the oncological safety and clinical impact of SLNB omission in patients with early-stage breast cancer and clinically intact axillary lymph nodes, and to define approaches to adjuvant therapy optimization in this cohort. Materials and methods. A prospective randomized non-inferiority trial is being conducted at the P.A. Herzen Moscow Oncology Research Institute. Patients with early-stage BC (cTis–cT2, cN0) were randomized 1:1 to SLNB or SLNB omission. In patients with cT1c–T2 disease, intraoperative fine-needle aspiration biopsy of the sentinel lymph node was additionally performed using a fan-shaped technique. The primary endpoint is disease-free survival. Secondary endpoints include overall survival, distant metastasis-free survival, locoregional and axillary recurrence rates, and quality-of-life characteristics. Results. The preliminary analysis included 151 patients. In the cT1a–b cohort assigned to SLNB omission, no lymph node metastases were identified. In the SLNB control group, metastases were detected in 12.5 % of patients, with involvement limited to no more than one lymph node in all cases. In the cT1c–T2 cohort, the metastatic involvement rate was 16.5 %. Intraoperative fine-needle aspiration biopsy of the sentinel lymph node demonstrated a sensitivity of 57.1 %, specificity of 100 %, positive predictive value of 100 %, and negative predictive value of 92.8 %. Favorable biological subtypes (luminal tumors) and low-to-intermediate histological grades predominated in the study population. Conclusion. Preliminary findings suggest potential oncological safety of SLNB omission in carefully selected patients with early-stage breast cancer and cN0 status. Rigorous preoperative axillary assessment using imaging modalities is a prerequisite. Further patient recruitment and extended follow-up are required to enable definitive evaluation of long-term oncological outcomes and to refine criteria for axillary surgical de-escalation.

15 September 2026 in Voprosy onkologii
Verified
Journal Article
Open access
PDF file
ДКДали Багаудиновна Кодзоева
Дали Багаудиновна Кодзоева
АЗАзиз Дильшодович Зикиряходжаев
Азиз Дильшодович Зикиряходжаев
ДДДжамиля Шринбековна Джабраилова
Джамиля Шринбековна Джабраилова
КМКирилл Владимирович Максимов
Кирилл Владимирович Максимов
НЗНадир Дамирович Замалдинов
Надир Дамирович Замалдинов
ФХФатима Славиковна Хугаева
Фатима Славиковна Хугаева
Введение. В данном систематическом обзоре проанализировано влияние биопсии сторожевого лимфатического узла (БСЛУ) на долгосрочные онкологические результаты у пациенток с клинически верифицированным поражением аксиллярных лимфатических узлов при раке молочной железы после неоадъювантной химиотерапии (НАПХТ) и достижение клинического ответа. Основная цель — оценить, обеспечивает ли БСЛУ при достижении клинического ответа в регионарных зонах сопоставимые показатели общей (ОВ) и безрецидивной выживаемости (БРВ) по сравнению со стандартной аксиллярной лимфодиссекцией (АЛД). Материалы и методы. Поиск литературы проведен в марте 2025 г. в базах PUBMED и Google Scholar с использованием ключевых слов breast neoplasm, node-positive, neoadjuvant chemotherapy, long-term survival, а также ручным просмотром списков ссылок включенных статей. В обзор включались рандомизированные контролируемые исследования и ретроспективные когортные исследования, оценившие отдаленные показатели ОВ, БРВ и частоту аксиллярных рецидивов в группе пациентов с клинически верифицированным поражением аксиллярных лимфатических узлов и полным клиническим регрессом после НАПХТ в зависимости от выполненного хирургического вмешательства на регионарном лимфоколлекторе. Отбор литературы и извлечение данных выполнялись двумя независимыми рецензентами по рекомендациям PRISMA с оценкой риска смещений шкалой Newcastle–Ottawa. Результаты. Из 341 найденного источника отобрано 20 исследований для систематического обзора. Пятилетняя ОВ в группах БСЛУ и АЛД составила 93,3 и 80,0 % соответственно, а БРВ — 84,7 и 73,2 % (p = 0,001). Частота аксиллярных рецидивов в обеих группах оставалась низкой и статистически не различалась (0,3–0,9 % для БСЛУ против 0,4–0,6 % для АЛД). Выводы. Объем хирургического вмешательства в регионарных зонах не показал статистически значимого влияния на отдаленные показатели выживаемости пациенток при раке молочной железы с поражением лимфатических узлов и полной клинической регрессией после НАПХТ, однако требуются результаты крупных рандомизированных исследований высокого качества с отдельным анализом подгрупп.